What is Neurocrine Biosciences's thereafter?

Neurocrine Biosciences (NBIX) reported thereafter of $306.90M in Q1 2026.

How has Neurocrine Biosciences's thereafter changed year-over-year?

Neurocrine Biosciences's thereafter decreased by 18.0% year-over-year, from $374.40M to $306.90M.

Thereafter

Neurocrine Biosciences Thereafter decreased by 17.4% to $306.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 18.0%, from $374.40M to $306.90M.

Analysis

StatementBalance Sheet Statement

SectionOther

First reportedQ2 2020

Last reportedQ1 2026May 5, 2026

Metric ID: other_lessee_operating_lease_liability_payments_due_afte_6444cc

Historical Data

15 periods

	Q2 '21	Q3 '21	Q1 '22	Q2 '22	Q3 '22	Q1 '23	Q2 '23	Q3 '23	Q1 '24	Q2 '24	Q3 '24	Q1 '25	Q2 '25	Q3 '25	Q1 '26
Value	$85.40M	$85.40M	$70.40M	$70.40M	$70.40M	$54.40M	$54.40M	$54.40M	$211.40M	$220.30M	$220.40M	$374.40M	$374.40M	$371.60M	$306.90M
QoQ Change	—	+0.0%	-17.6%	+0.0%	+0.0%	-22.7%	+0.0%	+0.0%	+288.6%	+4.2%	+0.0%	+69.9%	+0.0%	-0.7%	-17.4%
YoY Change	—	—	—	-17.6%	-17.6%	-22.7%	-22.7%	-22.7%	+288.6%	+305.0%	+305.1%	+77.1%	+70.0%	+68.6%	-18.0%

Range$54.40M – $374.40M

CAGR+44.1%

Avg YoY Growth+82.8%

Median YoY Growth+25.5%

Current Streak2 quarters decline

Frequently Asked Questions

What is Neurocrine Biosciences's thereafter?: Neurocrine Biosciences (NBIX) reported thereafter of $306.90M in Q1 2026.
How has Neurocrine Biosciences's thereafter changed year-over-year?: Neurocrine Biosciences's thereafter decreased by 18.0% year-over-year, from $374.40M to $306.90M.